| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700781 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages |
Abstract
In this study, the incidence of MMs and ITCs in patients with stage I/II colon cancer was 4.2% and 19.3%, respectively. MMs were associated with an reduced 3 year disease free survival rate, but ITCs were not.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
D.A.M. Sloothaak, R.L.A. van der Linden, C.J.H. van de Velde, W.A. Bemelman, D.J. Lips, J.C. van der Linden, H. Doornewaard, P.J. Tanis, K. Bosscha, E.S. van der Zaag, C.J. Buskens,